Abstract
Anti-Kp(a) is an irregular antibody of clinical significance directed against the red blood cell antigen Kp(a) of the Kell system. It is rare in the general population and, therefore, uncommon as a cause of transfusion or hemolytic complications. It has been documented in isolated cases, mainly in the context of alloimmunization after transfusion exposure or during pregnancy; its incidence in clinical practice is limited and can be difficult to detect in routine pre-transfusion testing, which could lead to failure to identify the antibody prior to transfusion. The production of Anti-Kp(a) antibodies is less common than antibodies against other Kell system antigens, such as anti-K. However, when generated, these antibodies can mediate hemolytic reactions in patients receiving incompatible blood and can cause hemolytic disease in the fetus since in addition to immune destruction of red blood cells, Kell system antibodies such as Anti-Kp(a) can cause suppression of fetal erythropoiesis, resulting in severe anemia.